Charles Schwab Investment Management »

Aktis Oncology shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Aktis Oncology (AKTS) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Aktis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Aktis Oncology held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aktis Oncology by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.9M 162k 17.89

More positions owned by Charles Schwab Investment Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Fundamental Us L (FNDX)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Schwab Strategic Tr Fundamental Intl (FNDF)
Chevron Corporation (CVX)
Home Depot (HD)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)
Merck & Co (MRK)

View all positions for Charles Schwab Investment Management

Top funds holding Aktis Oncology

MPM Oncology Impact Management
EcoR1 Capital
Blue Owl Capital Holdings
Wellington Management Company
BlackRock
Rtw Investments
RA Capital Management
Henderson Group
Baker Bros. Advisors
Octagon Capital Advisors
Merck & Co
Vanguard Capital Management
Eventide Asset Management
Geode Capital Management
Avidity Partners Management

View all funds holding Aktis Oncology